Transcatheter Aortic Valve Replacement is Ready for Most Low-risk Patients: A Systematic Review of the Literature

Authors

Ahmad Jabri, Henry Ford HealthFollow
Anas Alameh, Henry Ford Health
Gennaro Giustino, Henry Ford HealthFollow
Pedro Engel Gonzalez, Henry Ford HealthFollow
Brian O'Neill
Rodrigo Bagur
Pedro Cox
Tiberio Frisoli, Henry Ford HealthFollow
James Lee, Henry Ford HealthFollow
Dee Dee Wang, Henry Ford HealthFollow
William W. O'Neill, Henry Ford HealthFollow
Pedro Villablanca, Henry Ford HealthFollow

Recommended Citation

Jabri A, Alameh A, Giustino G, Gonzalez PE, O'Neill B, Bagur R, Cox P, Frisoli T, Lee J, Wang DD, O'Neill WW, and Villablanca P. Transcatheter Aortic Valve Replacement is Ready for Most Low-risk Patients: A Systematic Review of the Literature. Card Fail Rev 2024; 10:e11.

Document Type

Article

Publication Date

9-2024

Publication Title

Card Fail Rev

Abstract

Transcatheter aortic valve replacement (TAVR) has undergone rapid expansion, emerging as a viable therapeutic option for low-risk patients in lieu of surgical aortic valve replacement. This paper aims to provide a review of the scientific evidence concerning TAVR in low-risk patients, encompassing both observational and clinical trial data. Furthermore, a substantial proportion of low-risk patients possesses a bicuspid aortic valve, necessitating careful examination of the pertinent anatomic and clinical considerations to TAVR that is highlighted in this review. Additionally, the review expands upon some of the unique challenges associated with alternate access in low-risk patients evaluated for TAVR. Last, this review outlines the pivotal role of a multidisciplinary heart team approach in the execution of all TAVR procedures and the authors' vision of 'minimalist TAVR' as a new era in low-risk TAVR.

PubMed ID

39386082

Volume

10

First Page

11

Last Page

11